Drug Repositioning for the Treatment of Glioma: Current State and Future Perspective

Gliomas are the most common primary brain tumors. Among them, glioblastoma (GBM) possesses the most malignant phenotype. Despite the current standard therapy using an alkylating anticancer agent, temozolomide, most patients with GBM die within 2 years. Novel chemotherapeutic agents are urgently need...

Descripción completa

Detalles Bibliográficos

Autores principales:	Tamai, Sho, Hirai, Nozomi, Jiapaer, Shabierjiang, Furuta, Takuya, Nakada, Mitsutoshi
Formato:	Capítulo de libro
Lenguaje:	inglés
Publicado:	IntechOpen 2020
Materias:	Health Sciences
Acceso en línea:	https://www.intechopen.com/chapters/72600
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!